Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia

Gene Therapy volume 11, pages 1540–1548 (2004)Cite this article

Abstract

We tested the efficacy of low-density lipoprotein receptor (LDLR) therapy using helper-dependent adenovirus (HD-Ad), comparing it with that of very low-density lipoprotein receptor (VLDLR), an LDLR homolog. We treated high cholesterol diet fed LDLR−/− mice with a single intravenous injection of HD-Ad expressing monkey LDLR (1.5 × 1013 or 5 × 1012 VP/kg) or VLDLR. Throughout the 24-week experiment, plasma cholesterol of LDLR-treated mice was lower than that of VLDLR-treated mice, which was in turn lower than that of PBS-treated mice. Anti-LDLR antibodies developed in 2/10 mice treated with high-dose HD-Ad-LDLR but in none (0/14) of the other treatment groups. HD-Ad-treated mice displayed significant retardation of atherosclerotic lesion progression. We next tested the long-term efficacy of low-dose HD-Ad-LDLR injected into 12-week-old LDLR−/− mice. After 60 weeks, atherosclerosis lesions covered ∼50% of the surface of aortas of control mice, whereas aortas of treated mice were essentially lesion-free. The lipid lowering effect of HD-Ad-LDLR lasted at least 108 weeks (>2 years) when all control mice had died. In addition to retarding lesion progression, treatment caused lesion remodeling from a vulnerable-looking to a more stable-appearing phenotype. In conclusion, HD-Ad-mediated LDLR gene therapy is effective in conferring long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia.

This is a preview of subscription content, access via your institution

Access options

Buy this article

  • Purchase on Springer Link
  • Instant access to full article PDF
Buy now

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2
Figure 3
Figure 4
Figure 5
Figure 6
Figure 7
Figure 8

Similar content being viewed by others

References

  1. Goldstein JL, Brown MS . Atherosclerosis: the low-density lipoprotein receptor hypothesis. Metabolism 1977; 26: 1257–1275.

    Article  CAS  Google Scholar 

  2. Goldstein JL, Hobbs HH, Brown MS . Familial hypercholesterolemia. In: Scriver CR, Beaudet AL, Sly WS (eds). The Metabolic and Molecular Bases of Inherited Disease. McGraw-Hill: New York, 1995, pp 1981–2030.

    Google Scholar 

  3. Hopkins PN . Familial hypercholesterolemia – improving treatment and meeting guidelines. Int J Cardiol 2003; 89: 13–23.

    Article  Google Scholar 

  4. Yokoyama S, Hayashi R, Satani M, Yamamoto A . Selective removal of low density lipoprotein by plasmapheresis in familial hypercholesterolemia. Arteriosclerosis 1985; 5: 613–622.

    Article  CAS  Google Scholar 

  5. Yamamoto A, Harada-Shiba M, Kawaguchi A, Tsushima M . Apheresis technology for prevention and regression of atherosclerosis. Ther Apher 2001; 5: 221–225.

    Article  CAS  Google Scholar 

  6. Grossman M et al. A pilot study of ex vivo gene therapy for homozygous familial hypercholesterolaemia. Nat Med 1995; 1: 1148–1154.

    Article  CAS  Google Scholar 

  7. Ishibashi S et al. Hypercholesterolemia in low density lipoprotein receptor knockout mice and its reversal by adenovirus-mediated gene delivery. J Clin Invest 1993; 92: 883–893.

    Article  CAS  Google Scholar 

  8. Kozarsky KF et al. In vivo correction of low density lipoprotein receptor deficiency in the Watanabe heritable hyperlipidemic rabbit with recombinant adenoviruses. J Biol Chem 1994; 269: 13695–13702.

    CAS  Google Scholar 

  9. Li J et al. In vivo gene therapy for hyperlipidemia: phenotypic correction in Watanabe rabbits by hepatic delivery of the rabbit LDL receptor gene. J Clin Invest 1995; 95: 768–773.

    Article  CAS  Google Scholar 

  10. Chen SJ et al. Prolonged correction of hyperlipidemia in mice with familial hypercholesterolemia using an adeno-associated viral vector expressing very-low-density lipoprotein receptor. Mol Ther 2000; 2: 256–261.

    Article  CAS  Google Scholar 

  11. Kozarsky KF et al. Effective treatment of familial hypercholesterolaemia in the mouse model using adenovirus-mediated transfer of the VLDL receptor gene. Nat Genet 1996; 13: 54–62.

    Article  CAS  Google Scholar 

  12. Morral N et al. Administration of helper-dependent adenoviral vectors and sequential delivery of different vector serotype for long-term liver-directed gene transfer in baboons. Proc Natl Acad Sci USA 1999; 96: 12816–12821.

    Article  CAS  Google Scholar 

  13. Kim IH et al. Lifetime correction of genetic deficiency in mice with a single injection of helper-dependent adenoviral vector. Proc Natl Acad Sci USA 2001; 98: 13282–13287.

    Article  CAS  Google Scholar 

  14. Belalcazar LM et al. Long-term stable expression of human apolipoprotein A-I mediated by helper-dependent adenovirus gene transfer inhibits atherosclerosis progression and remodels atherosclerotic plaques in a mouse model of familial hypercholesterolemia. Circulation 2003; 107: 2726–2732.

    Article  CAS  Google Scholar 

  15. Oka K et al. Long-term stable correction of low-density lipoprotein receptor-deficient mice with a helper-dependent adenoviral vector expressing the very low-density lipoprotein receptor. Circulation 2001; 103: 1274–1281.

    Article  CAS  Google Scholar 

  16. Yamada N, Shames DM, Havel RJ . Effect of low density lipoprotein receptor deficiency on the metabolism of apolipoprotein B-100 in blood plasma. Kinetic studies in normal and Watanabe heritable hyperlipidemic rabbits. J Clin Invest 1987; 80: 507–515.

    Article  CAS  Google Scholar 

  17. James RW et al. Apolipoprotein B metabolism in homozygous familial hypercholesterolemia. J Lipid Res 1989; 30: 159–169.

    CAS  PubMed  Google Scholar 

  18. Kobayashi K et al. Reversal of hypercholesterolemia in low density lipoprotein receptor knockout mice by adenovirus-mediated gene transfer of the very low density lipoprotein receptor. J Biol Chem 1996; 271: 6852–6860.

    Article  CAS  Google Scholar 

  19. Suzuki J et al. Lipid accumulation and foam cell formation in Chinese hamster ovary cells overexpressing very low density lipoprotein receptor. Biochem Biophys Res Commun 1995; 206: 835–842.

    Article  CAS  Google Scholar 

  20. Galis ZS, Sukhova GK, Lark MW, Libby P . Increased expression of matrix metalloproteinases and matrix degrading activity in vulnerable regions of human atherosclerotic plaques. J Clin Invest 1994; 94: 2493–2503.

    Article  CAS  Google Scholar 

  21. Galis ZS . Atheroma morphology and mechanical strength: looks are important, after all – lose the fat. Circ Res 2000; 86: 1–3.

    Article  CAS  Google Scholar 

  22. Moreno PR et al. Macrophage infiltration in acute coronary syndromes. Implications for plaque rupture. Circulation 1994; 90: 775–778.

    Article  CAS  Google Scholar 

  23. Libby P et al. Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol 1996; 7: 330–335.

    Article  CAS  Google Scholar 

  24. Aikawa M et al. Lipid lowering by diet reduces matrix metalloproteinase activity and increases collagen content of rabbit atheroma: a potential mechanism of lesion stabilization. Circulation 1998; 97: 2433–2444.

    Article  CAS  Google Scholar 

  25. Aikawa M et al. Lipid lowering promotes accumulation of mature smooth muscle cells expressing smooth muscle myosin heavy chain isoforms in rabbit atheroma. Circ Res 1998; 83: 1015–1026.

    Article  CAS  Google Scholar 

  26. Verhamme P et al. Dietary cholesterol withdrawal reduces vascular inflammation and induces coronary plaque stabilization in miniature pigs. Cardiovasc Res 2002; 56: 135–144.

    Article  CAS  Google Scholar 

  27. Parks R, Evelegh C, Graham F . Use of helper-dependent adenoviral vectors of alternative serotypes permits repeat vector administration. Gene Therapy 1999; 6: 1565–1573.

    Article  CAS  Google Scholar 

  28. Parks RJ et al. A helper-dependent adenovirus vector system: removal of helper virus by Cre-mediated excision of the viral packaging signal. Proc Natl Acad Sci USA 1996; 93: 13565–13570.

    Article  CAS  Google Scholar 

  29. Morral N et al. Immune responses to reporter proteins and high viral dose limit duration of expression with adenoviral vectors: comparison of E2a wild type and E2a deleted vectors. Hum Gene Ther 1997; 8: 1275–1286.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

This work was supported by HL59314 and HL073144. We thank C Arden-Riley, M Merched-Sauvage, S Billah, and R Montgomery for their assistance in the study; L Pastore and A Beaudet for valuable discussion; S Kochanek and G Shiedner for providing 293Cre66 cells; M Krieger for CHO-ldlA7 cells; DP Via for providing I125-LDL; F Graham for providing helper virus; Merck & Co. for providing reagents developed by F Graham.

Author information

Authors and Affiliations

  1. Department of Molecular and Cellular Biology, Baylor College of Medicine, TX, USA

    S Nomura, A Merched, E Nour, C Dieker, K Oka & L Chan

  2. Department of Medicine, Baylor College of Medicine, TX, USA

    K Oka & L Chan

  3. Department of Neurology, Baylor College of Medicine, TX, USA

    K Oka

  4. St Luke's Episcopal Hospital, Houston, TX, USA

    L Chan

Authors
  1. S Nomura
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A Merched
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. E Nour
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. C Dieker
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. K Oka
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. L Chan
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nomura, S., Merched, A., Nour, E. et al. Low-density lipoprotein receptor gene therapy using helper-dependent adenovirus produces long-term protection against atherosclerosis in a mouse model of familial hypercholesterolemia. Gene Ther 11, 1540–1548 (2004). https://doi.org/10.1038/sj.gt.3302310

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.gt.3302310

Keywords

This article is cited by

Search

Advanced search

Quick links